Order results by:
| Issue | Title | |
| Vol 13, No 3 (2021) | Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults | Abstract similar documents |
| T. N. Pushkar, A. M. Azhigova, P. N. Vlasov, A. B. Kozhokaru | ||
| "... and tolerability. Patients and methods. We evaluated treatment effectiveness and tolerability and EAI in 89 adults ..." | ||
| Vol 12, No 3 (2020) | The efficiency and tolerability of lacosamide therapy in adolescents and adults with new-onset focal epilepsy in terms of the epileptiform activity index | Abstract PDF (Eng) similar documents |
| V. A. Karlov, P. N. Vlasov, A. B. Kozhokaru, A. S. Samoilov, A. S. Orlova | ||
| "... with quantification of the epileptiform activity index (EAI) at baseline and 1, 3, 6 and 12 months of treatment ..." | ||
| Vol 13, No 4 (2021) | Pharmacodynamic sodium channel blockers-induced seizure aggravation in patients with newly diagnosed focal epilepsy | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, A. M. Azhigova, A. B. Kozhokaru, A. S. Orlova | ||
| "... epilepsy receiving monotherapy with sodium channel blockers with epileptiform activity index (EAI ..." | ||
| Vol 15, No 3 (2023) | Safety and tolerability of repetitive transcranial magnetic stimulation: an analysis of over 1200 sessions | Abstract similar documents |
| I. S. Bakulin, A. Kh. Zabirova, A. G. Poydasheva, D. Yu. Lagoda, N. A. Suponeva, M. A. Piradov | ||
| "... , therefore, the issues of its safety and tolerability are especially important. Currently, serious adverse ..." | ||
| Vol 2, No 3 (2010) | Use of depakine chronosphere as a first monotherapy to treat epilepsy in children | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Rationale for mono- versus polytherapy with antiepileptic drugs for patients with epilepsy | Abstract similar documents |
| L. V. Lipatova, T. V. Kapustina | ||
| Vol 13, No 1 (2021) | Evaluation of the efficacy and tolerability of naftidrofuryl in the therapy of chronic cerebral ischemia | Abstract similar documents |
| M. N. Dadasheva, I. A. Zolotovskaya, R. V. Gorenkov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... Objective: to study the clinical efficacy and tolerability of naftidrofuryl (Duzofarm ..." | ||
| Vol 10, No 4 (2018) | Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner) | Abstract similar documents |
| P. N. Vlasov | ||
| "... The paper gives comparative data on the efficacy and tolerability of valproic acid (VA, valproate ..." | ||
| No 1S (2016): | Russian experience with perampanel in routine clinical practice | Abstract similar documents |
| V. A. Karlov, O. V. Belyaev, P. N. Vlasov, I. A. Zhidkova, I. V. Volkov, D. V. Dmitrenko, A. Yu. Karas, T. V. Kazennykh, O. I. Miguskina, A. V. Moskvicheva, E. N. Paramonova, I. V. Ponomareva, A. V. Chervyakov | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities | Abstract similar documents |
| I. G. Rudakova, Yu. A. Belova | ||
| "... , tolerability, and individual choice priorities. Patients and methods. The investigation enrolled 28 patients ..." | ||
| Vol 9, No 3 (2017) | Clinical results of and prospects for the use of controlled-release antiepileptic drugs: a new once-daily levetiracetam formulation | Abstract similar documents |
| P. N. Vlasov | ||
| Vol 2, No 2 (2010) | Cervicogenic headache: the specific features of complex therapy with Amelotex and CompligamV | Abstract similar documents |
| M. L. Pospelova | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... Objective: to evaluate the efficacy and tolerability of sustained-release sodium valproate sodium ..." | ||
| Vol 15, No 4 (2023) | Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko | ||
| "... Objective: to evaluate the pharmacokinetic parameters, safety and tolerability of Vespireit® (INN ..." | ||
| Vol 13, No 6 (2021) | Treatment of mixed anxiety and depressive disorder: results from a observational study of the efficacy and tolerability of agomelatine | Abstract similar documents |
| D. S. Petelin, I. V. Niinoya, O. V. Sorokina, D. V. Troshina, O. N. Voskresenskaya, B. A. Volel | ||
| "... Objective: to study the efficacy, safety and tolerability of agomelatine in mixed anxiety ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... Objective: to comparatively evaluate the clinical efficacy and tolerability of monotherapy ..." | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| Vol 1, No 3-4 (2009) | RUSSIAN OBSERVATIONAL SURVEY OF THE SHORT-TERM EFFICACY AND TOLERABILITY OF SUSTAINED-RELEASE SODIUM VALPROATE (DEPAKINE CHRONOSPHERA®) AS A FIRST-LINE DRUG IN THE TREATMENT OF EPILEPSY | Abstract similar documents |
| E. D. Belousova, A. Yu. Ermakov | ||
| "... good tolerability and efficacy, as well as easiness to use, in early preschool children in particular ..." | ||
| Vol 4, No 2 (2012) | The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders | Abstract similar documents |
| T G Voznesenskaya, N M Fokina | ||
| "... The objective of the investigation was to study the clinical efficacy, tolerability, and side ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... coronavirus infection. Objective: to evaluate the antidepressant efficacy and tolerability of agomelatine ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova | ||
| "... Objective: to analyze the efficacy and tolerability of sustained-release sodium valproate (SV ..." | ||
| Vol 1, No 1 (2009) | TENOTEN IN COMPLEX THERAPY FOR CEREBROVASCULAR INSUFFICIENCY IN ELDERLY PATIENTS | Abstract similar documents |
| L. D. Serova | ||
| "... Objective: to study the clinical efficacy and tolerability of tenoten versus cavinton in patients ..." | ||
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... patients with comorbidities, confirm the long-term efficacy and good tolerability of agomelatine in daily ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... efficacy and good tolerability. ..." | ||
| Vol 2, No 4 (2010) | Osteoarthrosis or osteoarthritis? The name of the disease through the eyes of a practitioner | Abstract similar documents |
| N. A. Khitrov | ||
| "... good tolerability. ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... , mechanisms of action, indications/contraindications, clinical effectiveness and tolerability, advantages ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... Objective: to evaluate the efficacy and tolerability of levetiracetam (LEV) (epiterra, TEVA ..." | ||
| Vol 5, No 2 (2013) | Locomotor therapy with extended-release crystalline glucocorticoids | Abstract similar documents |
| Vladimir Vasilyevich Badokin | ||
| "... , and shows predictable efficiency. This therapy shows good tolerability and high safety and prevents serious ..." | ||
| Vol 14, No 4 (2022) | Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease | Abstract similar documents |
| E. V. Yakovenko, F. A. Abbasov | ||
| "... in their correction. Piribedil, having a good safety and tolerability profile, and also, presumably, having a positive ..." | ||
| Vol 11, No 3 (2019) | Cognitive impairment in depression and Alzheimer's disease: differential diagnosis and approaches to therapy | Abstract similar documents |
| N. A. Tyuvina, S. V. Prokhorova, T. N. Maksimova, M. S. Verbitskaya | ||
| "... into account the efficacy and tolerability of the drugs at old age. ..." | ||
| Vol 5, No 2 (2013) | Dabigatran experience in primary and secondary prevention of cardioembolic stroke | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova | ||
| "... and nonvalvular atrial fibrillation. Dabigatran shows good tolerability and efficacy. Recurrent strokes were ..." | ||
| Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
| Vladimir Ernstovich Medvedev | ||
| "... .6%. There is evidence for the efficacy and tolerability of a number of psychotropic drugs. The administration ..." | ||
| Vol 8, No 2 (2016) | Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... study proved the efficacy, safety, and good tolerability of GA 40 mg TIW in patients with relapsing ..." | ||
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... .001) , to increase sedation (p<0.001) and to improve tolerability (p<0.001) . There is no recommended "overlap period ..." | ||
| Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
| A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
| "... : To investigate the safety, tolerability and efficacy of multitarget navigated TMS in PMS with CI. Material ..." | ||
| Vol 7, No 3 (2015) | Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision | Abstract similar documents |
| Irina Gennadyevna Rudakova, Yu. A. Belova | ||
| "... Institute in 2006–2007 (n=1200) and 2013–2014 (n=1450). The patients who had received initial therapy (n=384 ..." | ||
| Vol 10, No 4 (2018) | Pharmacogenetics of schizophrenia in real clinical practice: a clinical case | Abstract similar documents |
| R. F. Nasyrova, N. A. Schnaider, K. O. Mironov, G. A. Shipulin, O. P. Dribnokhodova, E. A. Golosov, M. Yu. Tolmachev, B. V. Andreev, A. A. Kurylev, L. Sh. Akhmetova, О. V. Limankin, N. G. Neznanov | ||
| "... range of adverse reactions (ARs). The clinical effect and tolerability of antipsychotics are variable ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... the high efficiency and good tolerability of agomelatine, an antidepressant with an innovative mechanism ..." | ||
| Vol 13, No 1 (2021) | Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, V. A. Parfenov, G. R. Tabeeva, D. V. Romanov, V. V. Osipova, Z. Katsarava | ||
| "... problems, and unsatisfactory tolerability of preventive pharmacotherapy for migraine. CBT could change ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... (of both original drugs and their analogues) that prove the high efficiency, safety, and tolerability ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... delivery system. This article reviews the clinical efficacy and tolerability of Rotigotine transdermal ..." | ||
| Vol 2, No 3 (2010) | Insomnia: clinical experience with Zolpidem (Sanval) | Abstract similar documents |
| Ya. I. Levin | ||
| "... and good tolerability of Sanval permit the latter to be assessed as an effective agent for the treatment ..." | ||
| Vol 15, No 5 (2023) | Diagnosis and treatment of depression according to the functional recovery paradigm | Abstract similar documents |
| G. M. Usov | ||
| "... that provides a broader therapeutic effect combined with a more favorable tolerability profile. Agomelatine ..." | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| "... ) poor tolerability due to frequent injections (every other day), 3) severe local reactions and flu-like ..." | ||
| Vol 16, No 5 (2024) | Muscle relaxers in acute musculoskeletal back pain | Abstract similar documents |
| A. Kh. Mukhametzyanova, A. I. Isaikin | ||
| "... of choice for ANBP. The results of randomized clinical trials have shown the efficacy and good tolerability ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
| Vol 12, No 1 (2020) | Comparative efficacy and tolerance of centrally acting muscle relaxants in elderly patients with nonspecific musculoskeletal pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, I. A. Zolotovskaya, V. A. Kruglov | ||
| "... Objective: to evaluate the clinical efficacy and tolerability of the Russian drug tolperisone ..." | ||
| Vol 11, No 4 (2019) | Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial) | Abstract similar documents |
| A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, N. V. Maslennikov, E. E. Tsukarzi, S. N. Mosolov, M. A. Piradov | ||
| "... of the technique. Objective: to compare of the effectiveness and tolerability of standard and personalized rTMS ..." | ||
| Vol 9, No 3 (2017) | Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke | Abstract similar documents |
| V. V. Gusev, O. A. Lvova, T. V. Balueva | ||
| "... Objective: to evaluate the safety, efficacy, and tolerability of the botulinum toxin A Relatox ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... , the presence of contraindications in a particular patient, tolerability, as well as territorial and economic ..." | ||
| Vol 15, No 6 (2023) | Choline alfoscerate in the correction of cognitive impairment | Abstract similar documents |
| O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova | ||
| "... at a dose of 1200 mg/day with donepezil at a dose of 10 mg/day may be recommended. Several studies have ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... aged from 40 to 90 years. Comparable safety and tolerability of Mexidol was demonstrated in middle ..." | ||
| Vol 13, No 6 (2021) | Novel approaches to the treatment of cervical dystonia. The concept of dual navigation control | Abstract PDF (Eng) similar documents |
| A. P. Kovalenko, Z. A. Zalyalova, A. F. Ivolgin | ||
| "... and tolerability of botulinum therapy in CD depends on the correct choice of target muscles and the accuracy ..." | ||
| Vol 13, No 5 (2021) | Effectiveness of early abobotulinum toxin (Dysport®) injections in patients with upper limb spastic paresis after traumatic brain injury in real clinical practice: results of a multicenter observational non-interventional prospective study (Adults with post Traumatic Brain Injury (TBI) upper limb (UL) spasticity – APTULS) | Abstract similar documents |
| S. E. Khatkova, V. P. Diagileva, L. V. Krylova, D. V. Pokhabov, A. G. Arutiunian | ||
| "... rehabilitation of patients with ULS in the early recovery period of TBI demonstrates its good tolerability ..." | ||
| Vol 15, No 2 (2023) | Optimization of migraine attacks relief | Abstract similar documents |
| G. R. Tabeeva, A. V. Amelin, L. R. Akhmadeeva, A. B. Danilov, O. B. Doronina, M. I. Koreshkina, N. V. Latysheva, E. G. Mendelevich, I. V. Sarvilina, A. V. Sergeev, K. V. Skorobogatykh, E. G. Filatova | ||
| "... , as well as for patients who have experience of poor efficacy and/or poor tolerability of other triptans ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | A patient with osteoarthritis out of a doctor's field of vision: how should joint pain be controlled within the concept of responsible self-treatment? | Abstract similar documents |
| A. E. Karateev | ||
| "... analgesic with good tolerability, standing out among all nonsteroidal anti-inflammatory drugs having ..." | ||
| Vol 11, No 4 (2019) | Cervicocranialgia: rationale for and evaluation of the clinical efficiency of therapy with the Russian generics of dexketoprofen and tolperisone | Abstract similar documents |
| M. N. Dadasheva, G. I. Nurullina, R. V. Gorenkov | ||
| "... combination treatment (Group 2). The therapy showed a high safety and a good tolerability. Conclusion ..." | ||
| Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
| A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
| "... tolerability and safety profile in patients with cerebrovascular diseases. ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... different types of seizures and forms of epilepsy, good tolerability, minimal aggravation risk, high ..." | ||
| Vol 9, No 3 (2017) | Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program | Abstract similar documents |
| G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva | ||
| "... % of physicians and patients assessed the efficacy and tolerability of treatment as good or excellent. Conclusion ..." | ||
| Vol 7, No 3 (2015) | Experience with sustained-release melatonin for the treatment of sleep disorders in depression | Abstract similar documents |
| Svetlana Vladimirovna Prokhorova, T. N. Maksimova | ||
| "... melatonin 2 mg has demonstrated high efficacy and good tolerability in the combination therapy of sleep ..." | ||
| Vol 7, No 3 (2015) | The heterogeneity of vascular cognitive impairments and the issues of therapy | Abstract similar documents |
| Elena Anatolyevna Katunina | ||
| "... into account its good tolerability and safety, the drug may be recommended for a wide circle of patients ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Experience of Using Vagus Nerve Stimulation to Treat Drug Resistant Epilepsy | Abstract similar documents |
| L. V. Lipatova, T. A. Skoromets, S. A. Gromov, S. D. Tabulina, A. V. Vtorov, M. M. Bondareva, A. G. Naryshkin, I. V. Galanin, S. A. Korovina, N. A. Sivakova, Yu. E. Mironenko | ||
| "... Objective. To determine tolerability and effectiveness of continuous vagus nerve stimulation ..." | ||
| Vol 4, No 2 (2012) | Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy | Abstract similar documents |
| O N Gerasimova, V A Parfenov | ||
| "... reduction (to 1—2 visual analog scale scores). Movalis therapy showed good tolerability and a low rate (1 ..." | ||
| Vol 4, No 4 (2012) | Poststroke depression: prevalence, pathogenesis, diagnosis, and treatment | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... on the high efficacy and good tolerability of escitalopram in poststroke depression. It is stressed ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... Objective: to study the clinical efficacy and tolerability of omberacetam in comparison ..." | ||
| Vol 16, No 3 (2024) | Therapeutic outcomes in patients with acute non-specific (musculoskeletal) pain according to the FORTE (ФОРТЕ) observational study | Abstract similar documents |
| V. A. Parfenov | ||
| "... and tolerability of the treatment. The patients were informed about the benign nature of the ANSBP and took ..." | ||
| Vol 12, No 4 (2020) | Depressions with eating disorders: clinical manifestations and therapy | Abstract similar documents |
| V. E. Medvedev, V. I. Frolova, E. V. Gushanskaya, Yu. S. Fofanova, S. E. Martynov, N. L. Zuikova, A. M. Burno, S. V. Nekrasova, I. V. Salyntsev | ||
| "... of the psychopharmacotherapeutic study was to evaluate the efficacy and tolerability of melatonergic monotherapy ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... a good tolerability, neither adverse events nor drug-drug interactions. Conclusion. When used in CCVD ..." | ||
| Online-first | Analysis of the association of the PRDM12 gene with pain sensitivity in individuals with psychoactive substance dependence | Abstract similar documents |
| E. G. Poltavskaya, D. N. Savochkina | ||
| "... , occasionally using psychoactive substances (risk group). Thresholds of pain sensitivity and tolerability ..." | ||
| 1 - 70 of 87 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
